Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
451 studies found for:    Open Studies | "Multiple Myeloma"
Show Display Options
Rank Status Study
21 Recruiting Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: ABBV-838
22 Not yet recruiting Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat
Condition: Multiple Myeloma
Interventions: Drug: Panobinostat;   Drug: Carfilzomib;   Drug: Lenalidomide;   Drug: Dexamethasone
23 Available Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple Myeloma
Conditions: Multiple Myeloma in Relapse;   Multiple Myeloma
Interventions: Drug: Ulocuplumab;   Drug: Lenalidomide;   Drug: Bortezomib;   Drug: Dexamethasone
24 Recruiting Value of Macrophage-Colony Stimulating Factor as a New Marker of Bone Lesions in Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Biological: blood samples;   Biological: Bone marow samples
25 Recruiting An Efficacy Study of Pomalidomide in Patient With Multiple Myeloma in Routine Clinical Practice
Condition: Multiple Myeloma
Intervention:
26 Recruiting Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Biological: Bortezomib;   Drug: G-CSF
27 Recruiting Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients
Condition: Multiple Myeloma
Interventions: Drug: Carfilzomib;   Drug: Cyclophosphamide;   Drug: Dexamethasone
28 Recruiting Clarithromycin Plus CTd Regimen for Patients With Newly Diagnosed Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Clarithromycin;   Drug: Thalidomide;   Drug: Cyclophosphamide;   Drug: Dexamethasone
29 Recruiting Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Plitidepsin;   Drug: Bortezomib;   Drug: Dexamethasone
30 Not yet recruiting Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Metformin XR;   Drug: Dexamethasone
31 Recruiting Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Daratumumab
32 Recruiting Pharmacokinetic Study of Propylene Glycol-Free Melphalan HCl for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Condition: Multiple Myeloma
Intervention: Drug: Melphalan HCl for injection (propylene glycol free)
33 Recruiting A Study to Determine the Efficacy, Safety and Pharmacokinetics of GMI-1271 as Adjunct to Standard of Care for the Treatment of Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: GMI-1271
34 Recruiting Study of Pomalidomide and Low Dose Dexamethasone With or Without Pembrolizumab (MK-3475) in Refractory or Relapsed and Refractory Multiple Myeloma (rrMM) (MK-3475-183/KEYNOTE-183)
Condition: Multiple Myeloma
Interventions: Biological: Pembrolizumab;   Drug: Pomalidomide;   Drug: Dexamethasone
35 Recruiting A Study of Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Daratumumab Subcutaneous (SC) infusion;   Drug: Recombinant Human Hyaluronidase [rHuPH20]) SC infusion;   Drug: Daratumumab Intravenous (IV) infusion
36 Recruiting Haploidentical Bone Marrow Stem Cell Transplantation in Patients With Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Procedure: Donor Bone Marrow stem cell transplantation
37 Not yet recruiting A Phase 1b Study of PVX-410, a Multi-Peptide Cancer Vaccine, and Durvalumab (Anti-PDL1) With and Without Lenalidomide for Patients With Smoldering Multiple Myeloma
Condition: Smoldering Multiple Myeloma
Interventions: Drug: Hiltonol;   Drug: Durvalumab;   Drug: Lenalidomide;   Biological: PVX-410
38 Not yet recruiting A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment
Condition: Multiple Myeloma
Interventions: Drug: Venetoclax;   Drug: ABBV-838;   Drug: Dexamethasone
39 Recruiting Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: I-131-CLR1404;   Drug: dexamethasone
40 Recruiting Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib
Condition: Multiple Myeloma
Interventions: Drug: Carfilzomib;   Drug: Dexamethasone;   Drug: Prednisone;   Drug: Methylprednisolone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.